Average Co-Inventor Count = 5.30
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enanta Pharmaceuticals, Inc. (11 from 290 patents)
2. Abbvie Inc. (1 from 822 patents)
3. Abbvie Bahamas Limited (6 patents)
4. Abbvie Ireland Unlimited Company (0 patent)
11 patents:
1. 9309279 - Macrocyclic hepatitis C serine protease inhibitors
2. 8962551 - Quinoxalinyl derivatives
3. 8809264 - Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors
4. 8785377 - Tetrazolyl macrocyclic hepatitis C serine protease inhibitors
5. 8501681 - Macrocyclic hepatitis C virus serine protease inhibitors
6. 8426360 - Carbocyclic oxime hepatitis C virus serine protease inhibitors
7. 8304385 - Macrocyclic tetrazolyl hepatitis C serine protease inhibitors
8. 8283309 - Bridged carbocyclic oxime hepatitis C virus serine protease inhibitors
9. 8211891 - Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors
10. 7605126 - Acylaminoheteroaryl hepatitis C virus protease inhibitors
11. 7582605 - Phosphorus-containing hepatitis C serine protease inhibitors